Background Patients with atrial fibrillation (AF) often require anticoagulation and platelet
inhibition, but data are limited on the bleeding risk of combination therapy. Methods We …

Background: Atrial fibrillation is a common arrhythmia associated with excess morbidity and
mortality. We studied temporal changes in hospital admission rates for atrial fibrillation using …

Aims To study initiation, dosages, and compliance with beta-blockers, angiotensin-converting
enzyme (ACE)-inhibitors, and statins in patients after acute myocardial infarction (AMI) and …

Background Accumulating evidence indicates increased cardiovascular risk associated with
nonsteroidal anti-inflammatory drug (NSAID) use, in particular in patients with established …

The Copenhagen City Heart Study is a population-based cohort study. Using baseline data
from 3 cohort examinations (1976 to 1978, 1981 to 1983, and 1991 to 1994), we analyzed …

Background— Undertreatment with recommended pharmacotherapy is a common problem
in heart failure and may influence prognosis. We studied initiation and persistence of …

Atrial fibrillation (AF) is the most frequently encountered cardiac arrhythmia. It is a risk factor
for stroke and premature death. We studied the temporal changes in the prevalence of AF …

Patients with untreated heart failure (HF) exhibit a blunted hemodynamic and neuroendocrine
response to a high sodium intake, leading to excessive sodium and water retention. …

Aims It is presently unknown whether patients with atrial fibrillation (AF) are at increased risk
of thrombo-embolic adverse events after interruption of warfarin treatment. The purpose of …

Objective: To investigate trends in case-fatality and prognostic impact from recurrent acute
myocardial infarction (re-AMI) during 1985–2002. Design: Retrospective cohort study using …